| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0006-8993(93)90309-B |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000689939390309B?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:000689939390309B?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 7693299 |
| P2093 | author name string | D. Benjamin | |
| L. A. Pohorecky | |||
| E. R. Grant | |||
| P2860 | cites work | Biochemical evidence for activation of specific monoamine pathways by ethanol | Q69055315 |
| Acute and chronic ethanol treatment on beta-endorphin and catecholamine levels | Q69301039 | ||
| Naloxone reduces alcohol intake in a free-choice procedure even when both drinking bottles contain saccharin sodium or quinine substances | Q70758898 | ||
| Multiple Opiate Receptors: Alcohol Selectively Inhibits Binding to Delta Receptors | Q72910230 | ||
| Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels | Q33340123 | ||
| Brain dopamine and reward | Q34498922 | ||
| Ethanol and opioid receptor signalling | Q34666518 | ||
| Effects of dexfenfluramine and opioid peptides, alone or in combination, on food intake and brain serotonin turnover in rats | Q41134831 | ||
| Drugs to decrease alcohol drinking | Q41221739 | ||
| Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats | Q41389778 | ||
| Constant infusions of morphine and intakes of sweetened ethanol solution among rats | Q41412150 | ||
| Focal application of alcohols elevates extracellular dopamine in rat brain: a microdialysis study | Q42476817 | ||
| Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis | Q42500821 | ||
| Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal rel | Q43661980 | ||
| The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study | Q43695146 | ||
| Importance of delta opioid receptors in maintaining high alcohol drinking | Q44333918 | ||
| Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats | Q48249444 | ||
| Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens | Q48590913 | ||
| Long term ethanol alters the binding of 3H-opiates to brain membranes | Q48759370 | ||
| Alcohol and the Opiate Receptor | Q48846843 | ||
| Naloxone alters alcohol drinking induced in the rat by tetrahydropapaveroline (THP) infused ICV | Q48951692 | ||
| Naloxone decreases ethanol consumption within a free choice paradigm in rats | Q62608787 | ||
| Ethanol-induced increase in endogenous dopamine release may involve endogenous opiates | Q68172536 | ||
| Alcohol drinking in rats during and following morphine injections | Q68249541 | ||
| Effects of 5,7-dihydroxytryptamine lesions of the nucleus accumbens on rat intravenous morphine self-administration | Q69002110 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 137-140 | |
| P577 | publication date | 1993-09-01 | |
| 1993-09-03 | |||
| P1433 | published in | Brain Research | Q4955782 |
| P1476 | title | Naltrexone reverses ethanol-induced dopamine release in the nucleus accumbens in awake, freely moving rats | |
| P478 | volume | 621 |
| Q46101192 | A novel and selective nociceptin receptor (NOP) agonist (1-(1-((cis)-4-isopropylcyclohexyl)piperidin-4-yl)-1H-indol-2-yl)methanol (AT-312) decreases acquisition of ethanol-induced conditioned place preference in mice |
| Q46032431 | Accumbens neurochemical adaptations produced by binge-like alcohol consumption. |
| Q48145962 | Acquisition and expression of ethanol-induced conditioned place preference in mice is inhibited by naloxone |
| Q43764443 | Acute ethanol administration differentially modulates mu opioid receptors in the rat meso-accumbens and mesocortical pathways |
| Q73934495 | Acute ethanol administration induces changes in TRH and proenkephalin expression in hypothalamic and limbic regions of rat brain |
| Q47901530 | Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. |
| Q73490177 | Alcohol, the brain, and behavior. Mechanisms of addiction |
| Q89639341 | Anhedonia as a key clinical feature in the maintenance and treatment of opioid use disorder |
| Q30363430 | Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone |
| Q57219650 | Basal levels and alcohol-induced changes in nociceptin/orphanin FQ, dynorphin, and enkephalin levels in C57BL/6J mice |
| Q42120031 | Behavioral and biochemical evidence of the role of acetaldehyde in the motivational effects of ethanol. |
| Q36178534 | Behavioral mechanisms underlying the link between smoking and drinking. |
| Q34616149 | Behavioral neurobiology of alcohol addiction: recent advances and challenges. |
| Q36906892 | Behavioural and physiological effects of electrical stimulation in the nucleus accumbens: a review. |
| Q44343370 | Central Opioid Receptors Differentially Regulate the Nalmefene-Induced Suppression of Ethanol- and Saccharin-Reinforced Behaviors in Alcohol-Preferring (P) Rats |
| Q59077974 | Combination pharmacotherapy in alcoholism: a novel treatment approach |
| Q44343839 | Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats |
| Q42149212 | Combining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism. |
| Q44338055 | Delta Opioid Pharmacology in Relation to Alcohol Behaviors. |
| Q36931792 | Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. |
| Q37144980 | Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans |
| Q43593969 | Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption |
| Q36824245 | Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people |
| Q44292706 | Effect of naltrexone on oral consumption of concurrently available ethanol and cocaine in the rat. |
| Q44695391 | Effect of the combination of naltrexone and acamprosate on alcohol intake in mice |
| Q34115849 | Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release. |
| Q44179056 | Effects of melanocortin receptor ligands on ethanol intake and opioid peptide levels in alcohol-preferring AA rats |
| Q38842262 | Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies. |
| Q73098641 | Effects of naltrexone on the accumulation of L-3, 4-dihydroxyphenylalanine and 5-hydroxy-L-tryptophan and on the firing rate induced by acute ethanol administration |
| Q40496894 | Endogenous opiates: 1993. |
| Q47963207 | Enhanced sensitivity of the nucleus accumbens proenkephalin system to alcohol in rats selectively bred for alcohol preference |
| Q52165518 | Ethanol enhances Nicotine's effects on DRL performance in rats. |
| Q48394198 | Ethanol exposure differentially alters pro-enkephalin mRNA expression in regions of the mesocorticolimbic system |
| Q48252540 | Ethanol induced differences in medial prefrontal cortex dopamine asymmetry and in nucleus accumbens dopamine metabolism in left- and right-turning rats |
| Q55475370 | Ethanol uses cAMP-independent signal transduction mechanisms to activate proenkephalin promoter activity in rat C6 glioma cells. |
| Q34424216 | Ethanol-enhanced GABA release: A focus on G protein-coupled receptors |
| Q48388258 | Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats |
| Q43719684 | Genetic analysis of the mu-opioid receptor in alcohol-dependent individuals |
| Q50195337 | Genetic differences in naloxone enhancement of ethanol-induced conditioned taste aversion |
| Q45151501 | IDRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of Spanish male alcoholic patients. |
| Q36540015 | Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues |
| Q48252557 | Left and right 6-hydroxydopamine lesions of the medial prefrontal cortex differentially affect voluntary ethanol consumption |
| Q43709825 | Locomotor-stimulating effects of indirect dopamine agonists are attenuated in Fawn hooded rats independent of postweaning social experience. |
| Q48131011 | Mmu and D2 receptor antisense oligonucleotides injected in nucleus accumbens suppress high alcohol intake in genetic drinking HEP rats |
| Q46577821 | Naloxone does not attenuate the locomotor effects of ethanol in FAST, SLOW, or two heterogeneous stocks of mice |
| Q34656944 | Naltrexone for the management of alcohol dependence |
| Q35894612 | Neurobiologic processes in drug reward and addiction |
| Q36076157 | Neuropeptides as mediators of the early-life impact on the brain; implications for alcohol use disorders |
| Q50065382 | Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence |
| Q50107527 | Open-label pilot study of injectable naltrexone for cannabis dependence |
| Q44337944 | Opioid antagonists and alcoholism treatment. |
| Q38035740 | Peter Riederer "70th birthday" neurobiological foundations of modern addiction treatment |
| Q77468736 | Pharmacological treatment of alcoholism |
| Q89905655 | Pharmacotherapeutic management of co-morbid alcohol and opioid use |
| Q36461774 | Pharmacotherapy for alcohol dependence: anticraving medications for relapse prevention. |
| Q30936896 | Pharmacotherapy of alcohol dependence: a review of the clinical data |
| Q35243743 | Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects |
| Q33750830 | Potent inhibition of alcohol self-administration in alcohol-preferring rats by a κ-opioid receptor antagonist |
| Q38837127 | Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status. |
| Q50067452 | Real-time assessment of alcohol craving and naltrexone treatment responsiveness in a randomized clinical trial. |
| Q34179928 | Region-specific induction of FosB/ΔFosB by voluntary alcohol intake: effects of naltrexone |
| Q44628777 | Reverse selection for differential response to the locomotor stimulant effects of ethanol provides evidence for pleiotropic genetic influence on locomotor response to other drugs of abuse |
| Q44342984 | Selective mu- and kappa-opioid receptor antagonists administered into the nucleus accumbens interfere with rapid tolerance to ethanol in rats |
| Q37432403 | Sex differences in NMDA receptor expression in human alcoholics. |
| Q37124698 | Stress, alcohol and drug interaction: an update of human research |
| Q48329536 | Suppression of ethanol-reinforced behavior by naltrexone is associated with attenuation of the ethanol-induced increase in dialysate dopamine levels in the nucleus accumbens. |
| Q34043568 | Synthesis and pharmacological evaluation of 6-naltrexamine analogs for alcohol cessation |
| Q46605162 | Systemic and intra-accumbens microinjections of naltrexone interfere with tolerance to ethanol in rats |
| Q48175552 | Tetrahydropapaveroline injected in the ventral tegmental area shifts dopamine efflux differentially in the shell and core of nucleus accumbens in high-ethanol-preferring (HEP) rats |
| Q42701015 | The Effects of Pharmacological Opioid Blockade on Neural Measures of Drug Cue-Reactivity in Humans |
| Q38775455 | The Role of NFkB in Drug Addiction: Beyond Inflammation. |
| Q51475488 | The effects of the naltrexone implant on rodent social interactions and cocaine-induced conditioned place preference. |
| Q35159235 | The nociceptin/orphanin FQ/NOP receptor system as a target for treatment of alcohol abuse: a review of recent work in alcohol-preferring rats |
| Q37300059 | The novel micro-opioid receptor antagonist, [N-allyl-Dmt(1)]endomorphin-2, attenuates the enhancement of GABAergic neurotransmission by ethanol |
| Q34543952 | The pharmacotherapy of alcohol dependence: a state of the art review |
| Q33784506 | The role of opioid-dopamine interactions in the induction and maintenance of ethanol consumption |
| Q31965867 | The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. |
| Q33997354 | The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration |
| Q39162974 | Urgency traits moderate daily relations between affect and drinking to intoxication among young adults |
| Q48557680 | Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain |
Search more.